BTAINasdaq United States
Market cap
$27.842 M
$0.90 +8.61%
Close of 7 Aug 2026
Revenue
$642.0K
#3533 by revenue
Earnings
-$69.9M
Loss-making
Shares outstanding
27,074,586
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for BioXcel Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.